Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas

Area of Science:

• Oncology
• Immunology
• Cell Biology

Background:

• Tumor cells evade complement-dependent cytotoxicity (CDC) using complement restriction factors (CRFs).
• CD46, CD55, and CD59 are key CRFs involved in immune evasion.
• CRF expression in head and neck squamous cell carcinoma (HNSCC) is not well understood.

Purpose of the Study:

• To compare CRF expression in non-neoplastic head and neck mucosa with HNSCC.
• To investigate CRF expression in oral squamous cell carcinoma (OSCC) cell lines.
• To determine if CRF overexpression occurs early in HNSCC tumorigenesis.

Main Methods:

• Immunohistochemical staining of normal mucosa and HNSCC tissues using anti-CRF monoclonal antibodies.
• Analysis of CRF expression in HNSCC tumor differentiation stages (poor, moderate, well).
• Laser scan fluorescence microscopy of OSCC cell lines (SCC12, SCC71) for CRF detection.

Main Results:

• CD46, CD55, and CD59 were highly expressed in HNSCC cells, including early stages (T1/T2N0M0).
• CRF expression was significantly lower or absent in non-neoplastic squamous epithelia and submucosa.
• OSCC cell lines also exhibited CRF expression.

Conclusions:

• CRFs are overexpressed in primary HNSCC tumors even before metastasis (N0M0 stage).
• Early overexpression of CRFs suggests their involvement in the initial stages of tumorigenesis.
• CRFs may represent an early mechanism for HNSCC to escape immune surveillance.